Beyond Type 1

Based in CA

🤖

AI Overview

With $0 in lobbying spend across 9 quarterly filings, Beyond Type 1 is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2022.

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2020	$0
2021	$0
2022	$0

Issues Lobbied

Health Issues

Lobbying Firms

Beyond Type 1

Lobbyists

Christel Aprigliano

Government Agencies Targeted

These are the government entities that Beyond Type 1 disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATECenters For Medicare and Medicaid Services (CMS)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Insulin, diabetes, CGM, DSMT

S.2199/H.R.4906 Insulin Price Reduction Act support, Special Diabetes Program (extension to 2024)

Insulin affordability

Prescription drug affordability

Improving diabetes device access

Support for H.R.379 Improving Social Determinants of Health Act of 2021

Insulin affordability

Prescription drug affordability

Improving diabetes device access

Support for H.R.379 Improving Social Determinants of Health Act of 2021

Support for S.1424 Chronic Disease Manage